The Medication Quantification Scale

Measurement of medication usage at a multidisciplinary pain center

Thomas Guck, Todd Fleischer, Elaine J. Pohren, LuAnn Tanner, Chris M. Criscuolo, Lyal G. Leibrock

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Program evaluation standards require pain centers to assess medication use as one of an array of outcome criteria. The Medication Quantification Scale (MQS) has been introduced as a continuous method for quantifying medication use in chronic nonmalignant pain patients that overcomes methodological concerns inherent in previous pain medication measures. The reliability and sensitivity to program effects of the MQS was demonstrated by the original authors. The present study reexamined the reliability and sensitivity, and provided evidence for the validity of the MQS in an effort to determine whether use of the MQS can be generalized to other pain centers. Interrater reliability between two nurses on 40 pretreatment and 40 6-month follow-up MQS scores were .958 (p <.0001) and .968 (p <.0001) respectively. Six month follow-up MQS scores were significantly lower than pretreatment MQS scores (t = 5.40, p <.0001) for 106 chronic nonmalignant pain patients treated at a multidisciplinary pain center. Convergent and divergent validity of the MQS were demonstrated by higher correlations between the MQS and conceptually similar rather than dissimilar outcome measures. The reliability, sensitivity, and validity of the MQS was demonstrated suggesting it can be generalized for program evaluation purposes to other pain centers.

Original languageEnglish
Pages (from-to)33-38
Number of pages6
JournalJournal of Back and Musculoskeletal Rehabilitation
Volume13
Issue number1
StatePublished - 1999

Fingerprint

Pain Clinics
Program Evaluation
Chronic Pain
Reproducibility of Results
Nurses
Outcome Assessment (Health Care)
Pain

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine
  • Rehabilitation
  • Health Professions(all)
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

The Medication Quantification Scale : Measurement of medication usage at a multidisciplinary pain center. / Guck, Thomas; Fleischer, Todd; Pohren, Elaine J.; Tanner, LuAnn; Criscuolo, Chris M.; Leibrock, Lyal G.

In: Journal of Back and Musculoskeletal Rehabilitation, Vol. 13, No. 1, 1999, p. 33-38.

Research output: Contribution to journalArticle

Guck, Thomas ; Fleischer, Todd ; Pohren, Elaine J. ; Tanner, LuAnn ; Criscuolo, Chris M. ; Leibrock, Lyal G. / The Medication Quantification Scale : Measurement of medication usage at a multidisciplinary pain center. In: Journal of Back and Musculoskeletal Rehabilitation. 1999 ; Vol. 13, No. 1. pp. 33-38.
@article{916f0613add94737acd446ded8b1076c,
title = "The Medication Quantification Scale: Measurement of medication usage at a multidisciplinary pain center",
abstract = "Program evaluation standards require pain centers to assess medication use as one of an array of outcome criteria. The Medication Quantification Scale (MQS) has been introduced as a continuous method for quantifying medication use in chronic nonmalignant pain patients that overcomes methodological concerns inherent in previous pain medication measures. The reliability and sensitivity to program effects of the MQS was demonstrated by the original authors. The present study reexamined the reliability and sensitivity, and provided evidence for the validity of the MQS in an effort to determine whether use of the MQS can be generalized to other pain centers. Interrater reliability between two nurses on 40 pretreatment and 40 6-month follow-up MQS scores were .958 (p <.0001) and .968 (p <.0001) respectively. Six month follow-up MQS scores were significantly lower than pretreatment MQS scores (t = 5.40, p <.0001) for 106 chronic nonmalignant pain patients treated at a multidisciplinary pain center. Convergent and divergent validity of the MQS were demonstrated by higher correlations between the MQS and conceptually similar rather than dissimilar outcome measures. The reliability, sensitivity, and validity of the MQS was demonstrated suggesting it can be generalized for program evaluation purposes to other pain centers.",
author = "Thomas Guck and Todd Fleischer and Pohren, {Elaine J.} and LuAnn Tanner and Criscuolo, {Chris M.} and Leibrock, {Lyal G.}",
year = "1999",
language = "English",
volume = "13",
pages = "33--38",
journal = "Journal of Back and Musculoskeletal Rehabilitation",
issn = "1053-8127",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - The Medication Quantification Scale

T2 - Measurement of medication usage at a multidisciplinary pain center

AU - Guck, Thomas

AU - Fleischer, Todd

AU - Pohren, Elaine J.

AU - Tanner, LuAnn

AU - Criscuolo, Chris M.

AU - Leibrock, Lyal G.

PY - 1999

Y1 - 1999

N2 - Program evaluation standards require pain centers to assess medication use as one of an array of outcome criteria. The Medication Quantification Scale (MQS) has been introduced as a continuous method for quantifying medication use in chronic nonmalignant pain patients that overcomes methodological concerns inherent in previous pain medication measures. The reliability and sensitivity to program effects of the MQS was demonstrated by the original authors. The present study reexamined the reliability and sensitivity, and provided evidence for the validity of the MQS in an effort to determine whether use of the MQS can be generalized to other pain centers. Interrater reliability between two nurses on 40 pretreatment and 40 6-month follow-up MQS scores were .958 (p <.0001) and .968 (p <.0001) respectively. Six month follow-up MQS scores were significantly lower than pretreatment MQS scores (t = 5.40, p <.0001) for 106 chronic nonmalignant pain patients treated at a multidisciplinary pain center. Convergent and divergent validity of the MQS were demonstrated by higher correlations between the MQS and conceptually similar rather than dissimilar outcome measures. The reliability, sensitivity, and validity of the MQS was demonstrated suggesting it can be generalized for program evaluation purposes to other pain centers.

AB - Program evaluation standards require pain centers to assess medication use as one of an array of outcome criteria. The Medication Quantification Scale (MQS) has been introduced as a continuous method for quantifying medication use in chronic nonmalignant pain patients that overcomes methodological concerns inherent in previous pain medication measures. The reliability and sensitivity to program effects of the MQS was demonstrated by the original authors. The present study reexamined the reliability and sensitivity, and provided evidence for the validity of the MQS in an effort to determine whether use of the MQS can be generalized to other pain centers. Interrater reliability between two nurses on 40 pretreatment and 40 6-month follow-up MQS scores were .958 (p <.0001) and .968 (p <.0001) respectively. Six month follow-up MQS scores were significantly lower than pretreatment MQS scores (t = 5.40, p <.0001) for 106 chronic nonmalignant pain patients treated at a multidisciplinary pain center. Convergent and divergent validity of the MQS were demonstrated by higher correlations between the MQS and conceptually similar rather than dissimilar outcome measures. The reliability, sensitivity, and validity of the MQS was demonstrated suggesting it can be generalized for program evaluation purposes to other pain centers.

UR - http://www.scopus.com/inward/record.url?scp=0033368884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033368884&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 33

EP - 38

JO - Journal of Back and Musculoskeletal Rehabilitation

JF - Journal of Back and Musculoskeletal Rehabilitation

SN - 1053-8127

IS - 1

ER -